Skip to main content

Table 1 Clinical characteristics of the study population and comparative effectiveness of FPT in TN

From: New high intensity fibreoptic phototherapy devices in healthy newborns: a single pad wrapped around the neonate body in comparison with a double pad device

 

TN group 1 (57)

TN group 2 (43)

P

Gestational age (wks)

38.6 ± 1.2

38.7 ± 1.2

0.68

Birthweight (g)

3288 ± 350

3277 ± 443

0.89

Gender (male)

31 (54.4)

25 (58,1)

0.71

AB0 mismatch

17 (29.8)

18 (41.9)

0.21

Rh mismatch

3 (5.3)

2 (4.6)

0.89

Cesarean section

7 (12.3)

4 (9.3)

0.64

Apgar score at 5’

9.7 ± 0.6

9.8 ± 0.4

0.51

SGA

0

0

 

Age at FPT start (h)

63 ± 22

64 ± 21

0.89

TSB at FPT start (mg/dl)

15.4 ± 2.1

15.9 ± 1.8

0.18

TSB at FPT stop (mg/dl)

11.0 ± 1.1

11.1 ± 1.3

0.59

FPT duration (h)

47.6 ± 18.8

42.7 ± 16.8

0.18

TSB reduction at stop of FPT (%)

27.6 ± 10.4

29.0 ± 10.0

0.51

TSB hourly reduction in PT (mg/dl/h)

0.11 ± 0.06

0.14 ± 0.15

0.17

TSB maximum rebound (%)

11.1 ± 26.6

13.0 ± 19.0

0.69

Check numbers after discharge

1.9 ± 1.4

1.6 ± 1.2

0.24

Birthweight variation (%)

3.6 ± 4.2

3.8 ± 3.2

0.79

Weight variation during phototherapy (%)

−1.9 ± 5.2

−2.3 ± 2.2

0.60

TSB reduction after 24 h of FPT (%)

16.0 ± 9.0

18.0 ± 9.0

0.27

  1. Data are expressed as mean ± SD or n. (%)